Fisher & Paykel Healthcare (NZSE:FPH) EV-to-EBITDA : 36.10 (As of May. 16, 2024)

View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Fisher & Paykel Healthcare's enterprise value is NZ$17,019 Mil. Fisher & Paykel Healthcare's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$471 Mil. Therefore, Fisher & Paykel Healthcare's EV-to-EBITDA for today is 36.10.

The historical rank and industry rank for Fisher & Paykel Healthcare's EV-to-EBITDA or its related term are showing as below:

NZSE:FPH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.41 Med: 23.47 Max: 50.11
Current: 36.11

During the past 13 years, the highest EV-to-EBITDA of Fisher & Paykel Healthcare was 50.11. The lowest was 12.41. And the median was 23.47.

NZSE:FPH's EV-to-EBITDA is ranked worse than
83.81% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.1 vs NZSE:FPH: 36.11

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Fisher & Paykel Healthcare's stock price is NZ$29.06. Fisher & Paykel Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$0.449. Therefore, Fisher & Paykel Healthcare's PE Ratio for today is 64.72.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Fisher & Paykel Healthcare EV-to-EBITDA Historical Data

The historical data trend for Fisher & Paykel Healthcare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare EV-to-EBITDA Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBITDA

Get a 7-Day Free Trial

26.52

40.03

22.57

22.93

35.65

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-EBITDA	Get a 7-Day Free Trial															-	22.93	-	35.65	-

Competitive Comparison of Fisher & Paykel Healthcare's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fisher & Paykel Healthcare's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's EV-to-EBITDA falls into.

Fisher & Paykel Healthcare EV-to-EBITDA Calculation

Fisher & Paykel Healthcare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	17019.406	/	471.4
	=	36.10

Fisher & Paykel Healthcare's current Enterprise Value is NZ$17,019 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$471 Mil.

Fisher & Paykel Healthcare (NZSE:FPH) EV-to-EBITDA Explanation

Fisher & Paykel Healthcare's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	29.06	/	0.449
	=	64.72

Fisher & Paykel Healthcare's share price for today is NZ$29.06.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$0.449.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Fisher & Paykel Healthcare EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.